-
Understanding schedule II drug procurement pathway, pricing and the impact of changing the National Drug Code (NDC) of a product
-
Evaluating the management and funding landscape for Duchenne Muscular Dystrophy (DMD) in Algeria, Tunisia and Morocco
-
Pricing and indication assessment for SIBO (small intestinal bacterial overgrowth) under Pediatric use Marketing Authorization (PUMA) regulations
-
Assessment of the perceived value of two PCV-20 pediatric vaccines and the possible P&MA outcomes in public and private market setting
-
Research study to support HPV vaccine manufacturer in understanding the value perception and price potential of their product in a private market setting
-
Defining the market access strategy for a new entrant in the crowded multiple sclerosis market
-
Stakeholder engagement planning for a novel breast cancer product
-
Assessing oncology portfolio to drive uptake through innovative contracting mechanism
-
Testing the perception of different free of charge programmes to support uptake
-
Pricing and market access strategy for a haematology product in the GCC
-
Assessment of a medical device to be used during liver transplants
-
Conducting a landscape assessment to understand the COVID-19 testing landscape in MENA
